Citadel Advisors’s ADARx Pharmaceuticals ADRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.8M Buy
+340,987
New +$6.82M ﹤0.01% 4311

Other funds holding ADRX

Citadel Advisors's ADRX Position: Q3 2026 in Review

Citadel Advisors opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 340,987 shares worth $6.8M. The stake represents ﹤0.01% of the portfolio and ranks #4311 among its holdings.

62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.

  • Citadel Advisors held 340,987 shares of ADARx Pharmaceuticals worth $6.8M as of Q3 2026.
  • ADARx Pharmaceuticals was a new Citadel Advisors position in Q3 2026.
  • ADARx Pharmaceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #4311 holding.
  • 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.

Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.